The hazard
Subpotent drug; Clavulanate Potassium component
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
- Brand / company
- Teva Pharmaceuticals USA, Inc
- Codes / lots
- Lot # 100062316, Exp Date: 01/2026
- Distribution
- Distributed in three (3) States: MS, OH, CA.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 12 Nov 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.